| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Advisor
1 company
Lewis Michael E is a Chief Scientific Advisor at Tvardi Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $1.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2016 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $10.93 | $79,373.66 | -2.3% | |
| Jul 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $11.66 | $84,674.92 | -2.2% | |
| Jun 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $9.50 | $68,989.00 | -2.2% | |
| May 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $10.64 | $77,267.68 | -2.1% | |
| Apr 1, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $9.90 | $71,893.80 | -2.1% | |
| Mar 2, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $10.11 | $73,418.82 | -2.0% | |
| Feb 2, 2015 | TVRD Tvardi Therapeutics, Inc. | Chief Scientific Advisor | Sell | 7,262 | $10.60 | $76,977.20 | -2.0% |